English | Español

Amgen Inc.
Press release submission | Dec 20, 2021

FDA Approves Otezla® (Apremilast) for the Treatment of Adult Patients With Plaque Psoriasis, Regardless of Severity Level

Press release submission | Sep 5, 2021

New Tezepelumab Data Show 86% Reduction In Exacerbations In Patients With Severe Asthma And Comorbid Nasal Polyps
Press release submission | Mar 15, 2019

AMGEN, INC.: Announces New Four-Year Outcomes Study To Examine Long-Term Effects Of Repatha® (evolocumab) In High-Risk Cardiovascular Disease (CVD) Patients Without Prior Heart Attack Or Stroke
Carol Ostrow | Dec 15, 2017

Amgen Foundation commits $500,000 to help southern California wildfire victims
Carol Ostrow | Dec 10, 2017

Amgen's Repatha wins FDA approval
Carol Ostrow | Dec 8, 2017

Amgen presents at Evercore conference
Mark Iandolo | Nov 1, 2017

Cancer information awareness campaign features conversations with Joan Lunden
Kathy Adams | Oct 22, 2017

Amgen, Boston Children's Hospital team up for study on unusual pain response

Trending
+ Technology/Innovation
Patient Daily News Service | Oct 9, 2025

Babylon Health collapse raises questions about AI claims across industries
Patient Daily | Oct 9, 2025

Medfluence Advisors Marketing Expert: 'The conversations leading into AAO-HNSF are shaping how ENT practices approach growth and engagement'
+ Pharmaceuticals
Patient Daily | Oct 8, 2025

American Lung Association launches campaign urging vaccinations against seasonal flu and respiratory illnesses
Patient Daily | Oct 6, 2025

Drug Channels Institute president: ‘A growing share of 340B dollars are captured by for-profit pharmacies and PBMs’